Graft versus Host Disease Practice Updates

Experts collaborate on 3 patient scenarios to review the current treatment paradigm of graft versus host disease in the context of key clinical trial data.

EP. 1: Virtual Tumor Board®: An Overview on Graft-Versus-Host Disease and Prophylaxis

March 31st 2022

Expert perspectives on the nature and occurrence of graft-versus-host disease alongside available prophylactic regimens.

EP. 2: Scenario 1: Acute GVHD Symptomology and Patient Education

April 1st 2022

Centering discussion on a patient scenario of acute graft-versus-host disease, participants discuss nuance in disease symptomology and patient education.

EP. 3: Scenario 1: Selecting Therapy for Acute Graft-Versus-Host Disease

April 1st 2022

A panel of experts discuss systemic therapy to manage a patient with acute graft-versus-host disease.

EP. 4: Scenario 1: Optimizing Management of Acute GVHD

April 1st 2022

Experts review the prognosis of a patient with acute graft-versus-host disease and identify ways to optimize their treatment strategies.

EP. 5: Scenario 2: Challenges in Early Intervention for Chronic GVHD

April 4th 2022

Shifting their focus to chronic graft-versus-host disease, experts review a patient scenario and discuss the challenges in early intervention.

EP. 6: Scenario 2: Identifying Chronic GVHD and Risk Status

April 4th 2022

Shared insight on how to distinguish chronic GVHD from acute GVHD, as well as utilize appropriate methods to risk stratify disease.

EP. 7: Scenario 2: Ibrutinib and Ruxolitinib as Treatment Options in cGVHD

April 4th 2022

A review of treatment options approved for steroid-refractory chronic graft-versus-host disease starting with ibrutinib and ruxolitinib.

EP. 8: Scenario 2: Belumosudil and Axatilimab as Treatment Options in cGVHD

April 4th 2022

Considerations for belumosudil and axatilimab as treatment options for steroid-refractory chronic graft-versus-host disease.

EP. 9: Scenario 2: Selecting Therapy for Steroid-Refractory GVHD

April 4th 2022

Having reviewed approved treatment options for steroid-refractory, chronic GVHD, experts discuss how they would address this patient scenario.

EP. 10: Scenario 2: Treatment-Induced Damage in Chronic GVHD

April 4th 2022

A brief discussion on the risk of treatment-induced damage when managing patients with chronic graft-versus-host disease.